Through the use of case examples and literature generated from the Severe and Refractory Disease Clinic at the University of Toronto and Mount Sinai Hospital, participants will have a better understanding on the use of various blood tests to assist with the diagnosis of these cases as well as the use of pharmacological and non-pharmacological modalities to help in the management of these challenging cases. We will also discuss the potential implications of this condition in treatment planning for implant-based dentistry.
- Learn and identify characteristics associated with Severe/Refractory Periodontal Disease
- Learn about the advanced diagnostic tools currently being utilized in this population of patients
- Learn how to manage these patients through conventional and pharmacological modalities
Bio: Dr. Michael Goldberg is currently an Associate Professor in the Discipline of Periodontics at the University of Toronto’s Faculty of Dentistry. He is the director of the Severe and Refractory Periodontal Disease Treatment Unit at the Faculty and the newly-formed Implant Monitoring Clinic, also at the Faculty. Dr. Goldberg has also taken on the clinical directorship of the Centre for Advanced Dental Research and Care (CADRC) at the Sinai Health System in Toronto. Dr. Goldberg is engaged in an overall review of the influence of systemic, genetic and environmental factors on the development and treatment of periodontal disease. In addition, he is the head of the division of Periodontology as well as an associate in the Wasser Pain Management Centre at Mount Sinai Hospital in Toronto. Dr. Goldberg is a partner in private specialty practice, limited to periodontics and implant surgery, in downtown Toronto.